| Published Application/Species/Sample/Dilution | Reference |
|---|
- immunohistochemistry; mouse; loading ...; fig 4d
| Xu B, Tian L, Chen J, Wang J, Ma R, Dong W, et al. An oncolytic virus expressing a full-length antibody enhances antitumor innate immune response to glioblastoma. Nat Commun. 2021;12:5908 pubmed publisher |
| Biniaris Georgallis S, Aschman T, Stergioula K, Schreiber F, Jafari V, Taranko A, et al. Amplification of autoimmune organ damage by NKp46-activated ILC1s. Nature. 2024;634:952-960 pubmed publisher |
| Luckett T, Abudula M, Ireland L, Glenn M, Bellomo G, Stafferton R, et al. Mesothelin Secretion by Pancreatic Cancer Cells Co-opts Macrophages and Promotes Metastasis. Cancer Res. 2024;84:527-544 pubmed publisher |
| Yoneda H, Mitsuhashi A, Yoshida A, Ogino H, Itakura S, Nguyen N, et al. Antipodoplanin antibody enhances the antitumor effects of CTLA-4 blockade against malignant mesothelioma by natural killer cells. Cancer Sci. 2024;115:357-368 pubmed publisher |
| Raufi A, Pellicciotta I, Palermo C, Sastra S, Chen A, Alouani E, et al. Cytotoxic chemotherapy potentiates the immune response and efficacy of combination CXCR4/PD-1 inhibition in models of pancreatic ductal adenocarcinoma. bioRxiv. 2023;: pubmed publisher |
| Bhin J, Yemelyanenko J, Chao X, Klarenbeek S, Opdam M, Malka Y, et al. MYC is a clinically significant driver of mTOR inhibitor resistance in breast cancer. J Exp Med. 2023;220: pubmed publisher |
| Farahmand P, Gyurászová K, Rooney C, Raffo Iraolagoitia X, Jayasekera G, Hedley A, et al. Asbestos accelerates disease onset in a genetic model of malignant pleural mesothelioma. Front Toxicol. 2023;5:1200650 pubmed publisher |
| Chibaya L, Murphy K, DeMarco K, Gopalan S, Liu H, Parikh C, et al. EZH2 inhibition remodels the inflammatory senescence-associated secretory phenotype to potentiate pancreatic cancer immune surveillance. Nat Cancer. 2023;4:872-892 pubmed publisher |
| Takasago T, Hayashi R, Ueno Y, Ariyoshi M, Onishi K, Yamashita K, et al. Anti-tumor necrosis factor-alpha monoclonal antibody suppresses colorectal cancer growth in an orthotopic transplant mouse model. PLoS ONE. 2023;18:e0283822 pubmed publisher |
| Hu J, S xe1 nchez Rivera F, Wang Z, Johnson G, Ho Y, Ganesh K, et al. STING inhibits the reactivation of dormant metastasis in lung adenocarcinoma. Nature. 2023;616:806-813 pubmed publisher |
| Lozano A, Souche F, Chavey C, Dardalhon V, Ramirez C, Vegna S, et al. Ras/MAPK signalling intensity defines subclonal fitness in a mouse model of hepatocellular carcinoma. elife. 2023;12: pubmed publisher |
| Zhang Z, Kong X, Ligtenberg M, van Hal van Veen S, Visser N, de Bruijn B, et al. RNF31 inhibition sensitizes tumors to bystander killing by innate and adaptive immune cells. Cell Rep Med. 2022;3:100655 pubmed publisher |
| Nixon B, Chou C, Krishna C, Dadi S, Michel A, Cornish A, et al. Cytotoxic granzyme C-expressing ILC1s contribute to antitumor immunity and neonatal autoimmunity. Sci Immunol. 2022;7:eabi8642 pubmed publisher |
| Parida P, Marquez Palencia M, Nair V, Kaushik A, Kim K, Sudderth J, et al. Metabolic diversity within breast cancer brain-tropic cells determines metastatic fitness. Cell Metab. 2022;34:90-105.e7 pubmed publisher |
| Qadir A, Guegan J, Ginestier C, Chaibi A, Bessede A, Charafe Jauffret E, et al. CD95/Fas protects triple negative breast cancer from anti-tumor activity of NK cells. iScience. 2021;24:103348 pubmed publisher |
| Fitzgerald A, Wang S, Agarwal V, Marcisak E, Zuo A, Jablonski S, et al. DPP inhibition alters the CXCR3 axis and enhances NK and CD8+ T cell infiltration to improve anti-PD1 efficacy in murine models of pancreatic ductal adenocarcinoma. J Immunother Cancer. 2021;9: pubmed publisher |
| Zhao N, Bardine C, Louren xe7 o A, Wang Y, Huang Y, Cleary S, et al. In Vivo Measurement of Granzyme Proteolysis from Activated Immune Cells with PET. ACS Cent Sci. 2021;7:1638-1649 pubmed publisher |
| Ciurkiewicz M, Floess S, Beckstette M, Kummerfeld M, Baumg xe4 rtner W, Huehn J, et al. Transcriptome analysis following neurotropic virus infection reveals faulty innate immunity and delayed antigen presentation in mice susceptible to virus-induced demyelination. Brain Pathol. 2021;31:e13000 pubmed publisher |
| Tello Lafoz M, Srpan K, Sanchez E, Hu J, Remšík J, Romin Y, et al. Cytotoxic lymphocytes target characteristic biophysical vulnerabilities in cancer. Immunity. 2021;54:1037-1054.e7 pubmed publisher |
| Bianchi A, Marchetti L, Hall Z, Lemos H, Vacca M, Paish H, et al. Moderate Exercise Inhibits Age-Related Inflammation, Liver Steatosis, Senescence, and Tumorigenesis. J Immunol. 2021;206:904-916 pubmed publisher |
| Wei D, Li D, Gu A, Ji W, Yang Y, Peng J. A novel Cytochrome P450 26A1 expressing NK cell subset at the mouse maternal-foetal interface. J Cell Mol Med. 2021;25:1771-1782 pubmed publisher |
| Calabrese D, Aminian E, Mallavia B, Liu F, Cleary S, Aguilar O, et al. Natural killer cells activated through NKG2D mediate lung ischemia-reperfusion injury. J Clin Invest. 2021;131: pubmed publisher |
| Jin W, Shi K, He W, Sun J, Van Kaer L, Shi F, et al. Neuroblast senescence in the aged brain augments natural killer cell cytotoxicity leading to impaired neurogenesis and cognition. Nat Neurosci. 2021;24:61-73 pubmed publisher |
| Kobia F, Preusse K, Dai Q, Weaver N, Hass M, Chaturvedi P, et al. Notch dimerization and gene dosage are important for normal heart development, intestinal stem cell maintenance, and splenic marginal zone B-cell homeostasis during mite infestation. PLoS Biol. 2020;18:e3000850 pubmed publisher |
| Hargrave A, Courson J, Pham V, Landry P, Magadi S, Shankar P, et al. Corneal dysfunction precedes the onset of hyperglycemia in a mouse model of diet-induced obesity. PLoS ONE. 2020;15:e0238750 pubmed publisher |
| Koundouros N, Karali E, Tripp A, Valle A, Inglese P, Perry N, et al. Metabolic Fingerprinting Links Oncogenic PIK3CA with Enhanced Arachidonic Acid-Derived Eicosanoids. Cell. 2020;181:1596-1611.e27 pubmed publisher |
| Yun J, Lee S, Kim S, Jeong S, Kim J, Pyo K, et al. Antitumor Activity of Amivantamab (JNJ-61186372), an EGFR-MET Bispecific Antibody, in Diverse Models of EGFR Exon 20 Insertion-Driven NSCLC. Cancer Discov. 2020;10:1194-1209 pubmed publisher |
| Ruscetti M, Morris J, Mezzadra R, Russell J, Leibold J, Romesser P, et al. Senescence-Induced Vascular Remodeling Creates Therapeutic Vulnerabilities in Pancreas Cancer. Cell. 2020;181:424-441.e21 pubmed publisher |
| Ireland L, Luckett T, Schmid M, Mielgo A. Blockade of Stromal Gas6 Alters Cancer Cell Plasticity, Activates NK Cells, and Inhibits Pancreatic Cancer Metastasis. Front Immunol. 2020;11:297 pubmed publisher |
| Del Prete A, Sozio F, Schioppa T, Ponzetta A, Vermi W, Calza S, et al. The Atypical Receptor CCRL2 Is Essential for Lung Cancer Immune Surveillance. Cancer Immunol Res. 2019;7:1775-1788 pubmed publisher |
| Su W, Han H, Wang Y, Zhang B, Zhou B, Cheng Y, et al. The Polycomb Repressor Complex 1 Drives Double-Negative Prostate Cancer Metastasis by Coordinating Stemness and Immune Suppression. Cancer Cell. 2019;36:139-155.e10 pubmed publisher |
| Davies A, Kim H, González Cano R, Choi J, Back S, Roh S, et al. Natural Killer Cells Degenerate Intact Sensory Afferents following Nerve Injury. Cell. 2019;176:716-728.e18 pubmed publisher |
| Nishina S, Yamauchi A, Kawaguchi T, Kaku K, Goto M, Sasaki K, et al. Dipeptidyl Peptidase 4 Inhibitors Reduce Hepatocellular Carcinoma by Activating Lymphocyte Chemotaxis in Mice. Cell Mol Gastroenterol Hepatol. 2019;7:115-134 pubmed publisher |
| Kikuchi N, Ye J, Hirakawa J, Kawashima H. Forced Expression of CXCL10 Prevents Liver Metastasis of Colon Carcinoma Cells by the Recruitment of Natural Killer Cells. Biol Pharm Bull. 2019;42:57-65 pubmed publisher |
| Janker F, Weder W, Jang J, Jungraithmayr W. Preclinical, non-genetic models of lung adenocarcinoma: a comparative survey. Oncotarget. 2018;9:30527-30538 pubmed publisher |
| Er E, Valiente M, Ganesh K, Zou Y, Agrawal S, Hu J, et al. Pericyte-like spreading by disseminated cancer cells activates YAP and MRTF for metastatic colonization. Nat Cell Biol. 2018;20:966-978 pubmed publisher |
| Singh K, Ji X, Singh S. Therapeutic Potential of Leelamine, a Novel Inhibitor of Androgen Receptor and Castration-Resistant Prostate Cancer. Mol Cancer Ther. 2018;17:2079-2090 pubmed publisher |
| Martin A, Seignez C, Racoeur C, Isambert N, Mabrouk N, Scagliarini A, et al. Tumor-derived granzyme B-expressing neutrophils acquire antitumor potential after lipid A treatment. Oncotarget. 2018;9:28364-28378 pubmed publisher |
| Turchinovich G, Ganter S, Bärenwaldt A, Finke D. NKp46 Calibrates Tumoricidal Potential of Type 1 Innate Lymphocytes by Regulating TRAIL Expression. J Immunol. 2018;200:3762-3768 pubmed publisher |
| Putz E, Mayfosh A, Kos K, Barkauskas D, Nakamura K, Town L, et al. NK cell heparanase controls tumor invasion and immune surveillance. J Clin Invest. 2017;127:2777-2788 pubmed publisher |
| Lagumersindez Denis N, Wrzos C, Mack M, Winkler A, van der Meer F, Reinert M, et al. Differential contribution of immune effector mechanisms to cortical demyelination in multiple sclerosis. Acta Neuropathol. 2017;134:15-34 pubmed publisher |
| Sung S, Ge Y, Dai C, Wang H, Fu S, Sharma R, et al. Dependence of Glomerulonephritis Induction on Novel Intraglomerular Alternatively Activated Bone Marrow-Derived Macrophages and Mac-1 and PD-L1 in Lupus-Prone NZM2328 Mice. J Immunol. 2017;198:2589-2601 pubmed publisher |
| Luu T, Ganesan S, Wagner A, Sarhan D, Meinke S, Garbi N, et al. Independent control of natural killer cell responsiveness and homeostasis at steady-state by CD11c+ dendritic cells. Sci Rep. 2016;6:37996 pubmed publisher |
| Krueger P, Narayanan S, Surette F, Brown M, Sung S, Hahn Y. Murine liver-resident group 1 innate lymphoid cells regulate optimal priming of anti-viral CD8+ T cells. J Leukoc Biol. 2017;101:329-338 pubmed publisher |
| Kritikou J, Dahlberg C, Baptista M, Wagner A, Banerjee P, Gwalani L, et al. IL-2 in the tumor microenvironment is necessary for Wiskott-Aldrich syndrome protein deficient NK cells to respond to tumors in vivo. Sci Rep. 2016;6:30636 pubmed publisher |
| Rabacal W, Pabbisetty S, Hoek K, Cendron D, Guo Y, Maseda D, et al. Transcription factor KLF2 regulates homeostatic NK cell proliferation and survival. Proc Natl Acad Sci U S A. 2016;113:5370-5 pubmed publisher |
